Other substances

Etanercept

A dimeric fusion protein anti-inflammatory drug.

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
4
 AI-suggested references
0
 Clinical trials

General information

Etanercept on DrugBank

Marketed as

BRENZYS; DAVICTREL; ENBREL; ERELZI; ETICOVO; TUNEX

 

Structure image - Etanercept

Supporting references

Link Tested on Impact factor Notes Publication date
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
Protein factor Small molecule Antibody In silico 		in silico (machine learning) 13.49

Considered by the authors to be among the most relevant drugs identified in a machine-learning algorithm-based screening of compounds which considers causal protein-protein interactions, known drug targets, and specific signalling circuits in the COVID-19 disease map.

 Dec/11/2020

AI-suggested references

Link Publication date
Targeting ectromelia virus and TNF/NF-kappaB or STAT3 signaling for effective treatment of viral pneumonia.
May/14/2020
TNF-alpha Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.
Jul/23/2021
A Computational-Based Drug Repurposing Method Targeting SARS-CoV-2 and its Neurological Manifestations Genes and Signaling Pathways
Jun/18/2021
Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19
Jul/20/2020
Export (.csv)